Ticker Details
Beam Therapeutics Inc.
IPO Date:	February 6, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.68B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.48 | 3.44%
Avg Daily Range (30 D):	$0.73 | 2.91%
Avg Daily Range (90 D):	$0.86 | 3.10%

Institutional Daily Volume
Avg Daily Volume:	1.02M
Avg Daily Volume (30 D):	1.82M
Avg Daily Volume (90 D):	1.59M

Trade Size
Avg Trade Size (Sh.):	59
Avg Trade Size (Sh.) (30 D):	57
Avg Trade Size (Sh.) (90 D):	56

Institutional Trades
Total Institutional Trades:	3,448
Avg Institutional Trade:	$3.15M
Avg Institutional Trade (30 D):	$3.11M
Avg Institutional Trade (90 D):	$3.36M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.93M
Avg Closing Trade (30 D):	$5.85M
Avg Closing Trade (90 D):	$5.74M
Avg Closing Volume:	144.66K

News

Apr 7, 2026 @ 5:44 PM Global DNA Read, Write and Edit Market to Surge to... Source: Bcc Research

Mar 25, 2026 @ 11:00 AM Beam Therapeutics Announces Compelling Updated Cli... Source: Na

Feb 24, 2026 @ 1:00 PM Kyverna Therapeutics Appoints Biotech Leaders Srav... Source: Na

Feb 24, 2026 @ 12:00 PM Beam Therapeutics Announces $500 Million Strategic... Source: Na

Feb 23, 2026 @ 9:00 PM Beam Therapeutics to Host Investor Webcast for Fou... Source: Na

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.81	$2.51	$-.81
Diluted EPS	$-.81	$2.51	$-.81
Revenue	$139.74M	$114.11M	$139.74M
Gross Profit
Net Income / Loss	$-79.99M	$244.3M	$-79.99M
Operating Income / Loss	$-383.69M	$-17.45M	$-383.69M
Cost of Revenue
Net Cash Flow	$11.51M	$27M	$11.51M
PE Ratio